The National Law Journal warns that penalties in the Sarbanes-Oxley accounting rules for public companies can extend to individuals and private entities.

Drug maker Cephalon receives approval from the FDA to sell a new anti-leukemia drug.

Restaurant owner Joe Vento creates controversy with a sign advising customers to order in English only.

John Berlau, director of CEI's Center for Entrepreneurship, debates Sarbanes-Oxley in the Economist

Contact: Christine Hall, 202.331.2258

Washington, D.C., June 7, 2007—Sarbanes-Oxley, the federal law aimed at protecting investors from corporate abuses, is actually hurting investors by preventing them from growing wealth, according to a new study by the Competitive Enterprise Institute.

Remember 1982, when video games, personal computers, and cordless phones were new—and the companies that made these products were new? If investors could travel back in time, some of them would have fun playing Pac-Man again, but all would love to load up on some of the many great stock bargains around then.